Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology
- PMID: 37191183
- PMCID: PMC10651802
- DOI: 10.1002/alz.13074
Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology
Abstract
Introduction: Growing evidence supports that dysfunctional autophagy, the major cell mechanism responsible for removing protein aggregates and a route of clearance for Tau in healthy neurons, is a major finding in demented Alzheimer's disease (AD) patients. However, the association of autophagy with maintenance of cognitive integrity in resilient individuals who have AD neuropathology but remain non-demented (NDAN) has not been evaluated.
Methods: Using post mortem brain samples from age-matched healthy control, AD, and NDAN subjects, we evaluated autophagy in relation to Tau pathology using Western blot, immunofluorescence and RNA-seq.
Results: Compared to AD patients, NDAN subjects had preserved autophagy and reduced tauopathy. Furthermore, expression of autophagy genes and AD-related proteins were significantly associated in NDAN compared to AD and control subjects.
Discussion: Our results suggest preserved autophagy is a protective mechanism that maintains cognitive integrity in NDAN individuals. This novel observation supports the potential of autophagy-inducing strategies in AD therapeutics.
Highlights: NDAN subjects have preserved autophagic protein levels comparable with control subjects. Compared to control subjects, NDAN subjects have significantly reduced Tau oligomers and PHF Tau phosphorylation at synapses that negatively correlate with autophagy markers. Transcription of autophagy genes strongly associates with AD-related proteins in NDAN donors.
Keywords: Alzheimer's disease; Tau; autophagy; resilience.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
CONFLICT OF INTERESTS
The authors declare no competing interests.
Similar articles
-
TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology.Brain Pathol. 2023 Jan;33(1):e13108. doi: 10.1111/bpa.13108. Epub 2022 Jul 11. Brain Pathol. 2023. PMID: 35816404 Free PMC article.
-
Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.J Alzheimers Dis. 2022;87(1):51-81. doi: 10.3233/JAD-210607. J Alzheimers Dis. 2022. PMID: 35275527 Free PMC article. Review.
-
Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.J Alzheimers Dis. 2020;78(4):1661-1678. doi: 10.3233/JAD-200716. J Alzheimers Dis. 2020. PMID: 33185603 Free PMC article.
-
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488. Cells. 2019. PMID: 31121890 Free PMC article. Review.
-
Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.Mol Neurodegener. 2012 May 28;7:23. doi: 10.1186/1750-1326-7-23. Mol Neurodegener. 2012. PMID: 22640423 Free PMC article.
Cited by
-
Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.Alzheimers Dement. 2024 Feb;20(2):783-797. doi: 10.1002/alz.13484. Epub 2023 Sep 30. Alzheimers Dement. 2024. PMID: 37777848 Free PMC article.
-
Alzheimer's Disease Treatment: The Search for a Breakthrough.Medicina (Kaunas). 2023 Jun 4;59(6):1084. doi: 10.3390/medicina59061084. Medicina (Kaunas). 2023. PMID: 37374288 Free PMC article. Review.
References
-
- 2020 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia [Internet]. 2020. Mar 1 [cited 2021 Jul 5];16(3):391–460. Available from: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12068 - DOI
-
- Glenner GG, Wong CW. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984. May 16;120(3):885–90. - PubMed
-
- Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences [Internet]. 1986. Jul 1 [cited 2023 Feb 13];83(13):4913–7. Available from: https://www.pnas.org/doi/abs/10.1073/pnas.83.13.4913 - DOI - PMC - PubMed
-
- Querfurth HW, LaFerla FM. Alzheimer’s Disease. https://doi.org/101056/NEJMra0909142 [Internet]. 2010. Jan 28 [cited 2022 Dec 11];362(4):329–44. Available from: https://www.nejm.org/doi/10.1056/NEJMra0909142 - DOI - PubMed
-
- Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol [Internet]. 2012. May [cited 2018 Nov 18];71(5):362–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22487856 - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical